Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Seamus Fernandez is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | HLVX | Buy Now | HilleVax | $1.67 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 04/29/2024 | ALT | Buy Now | Altimmune | $6.82 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 03/05/2024 | APGE | Buy Now | Apogee Therapeutics | $39.60 | 129.8% | $44 → $91 | Maintains | Buy | Get Alert |
| 03/04/2024 | GSK | Buy Now | GSK | $38.74 | — | — | Upgrade | Neutral → Buy | Get Alert |
| 01/03/2024 | APGE | Buy Now | Apogee Therapeutics | $39.60 | 11.11% | $29 → $44 | Maintains | Buy | Get Alert |
| 01/02/2024 | ICVX | Buy Now | Icosavax | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2023 | ICVX | Buy Now | Icosavax | — | — | → $28 | Initiates | → Buy | Get Alert |
| 11/15/2023 | HLVX | Buy Now | HilleVax | $1.67 | 1935.32% | $38 → $34 | Maintains | Buy | Get Alert |
| 08/15/2023 | VERV | Buy Now | Verve Therapeutics | $5.67 | 870.02% | $56 → $55 | Maintains | Buy | Get Alert |
| 08/11/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $20 | Initiates | → Buy | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $39.60 | -26.77% | → $29 | Initiates | → Buy | Get Alert |
| 07/14/2023 | ARCT | Buy Now | Arcturus Therapeutics | $22.21 | — | — | Maintains | Buy | Get Alert |
| 04/11/2023 | MRK | Buy Now | Merck & Co | $125.98 | -1.57% | $123 → $124 | Maintains | Buy | Get Alert |
| 04/11/2023 | LLY | Buy Now | Eli Lilly | $926.88 | -57.71% | $395 → $392 | Maintains | Buy | Get Alert |
| 03/29/2023 | ARCT | Buy Now | Arcturus Therapeutics | $22.21 | 62.09% | → $36 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $12.72 | 151.57% | → $32 | Initiates | → Buy | Get Alert |
| 02/28/2023 | PCVX | Buy Now | Vaxcyte | $81.55 | -20.29% | $66 → $65 | Maintains | Buy | Get Alert |
| 02/28/2023 | GPCR | Buy Now | Structure Therapeutics | $40.16 | 24.49% | → $50 | Initiates | → Buy | Get Alert |
| 01/11/2023 | ALBO | Buy Now | Albireo Pharma | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 12/15/2022 | PCVX | Buy Now | Vaxcyte | $81.55 | -19.06% | → $66 | Initiates | → Buy | Get Alert |
| 12/07/2022 | LLY | Buy Now | Eli Lilly | $926.88 | -56.74% | $399 → $401 | Maintains | Buy | Get Alert |
| 11/15/2022 | DICE | Buy Now | DICE Therapeutics | — | — | → $65 | Initiates | → Buy | Get Alert |
| 11/01/2022 | MRK | Buy Now | Merck & Co | $125.98 | -11.89% | $104 → $111 | Maintains | Buy | Get Alert |
| 10/10/2022 | MRK | Buy Now | Merck & Co | $125.98 | — | — | Upgrade | Neutral → Buy | Get Alert |
| 10/10/2022 | BMY | Buy Now | Bristol-Myers Squibb | $40.64 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 09/16/2022 | ALT | Buy Now | Altimmune | $6.82 | 281.51% | $31 → $26 | Maintains | Buy | Get Alert |
| 09/08/2022 | ALBO | Buy Now | Albireo Pharma | — | — | → $55 | Initiates | → Buy | Get Alert |
| 05/31/2022 | NVO | Buy Now | Novo Nordisk | $141.17 | — | — | Upgrade | Neutral → Buy | Get Alert |
| 05/24/2022 | HLVX | Buy Now | HilleVax | $1.67 | 2294.49% | → $40 | Initiates | → Buy | Get Alert |
| 12/15/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 12/07/2021 | MRK | Buy Now | Merck & Co | $125.98 | — | — | Downgrade | Buy → Neutral | Get Alert |
